Filing Flows › Comparisons › VRDN vs LFCR
Viridian Therapeutics vs Lifecore Biomedical: VRDN and LFCR compared
Viridian Therapeutics is the larger company: $25.8M of revenue in its latest quarter (Q3 2026) against $25.3M for Lifecore Biomedical (Q1 FY27). Lifecore Biomedical is growing faster (-19% against -64% a year earlier). Lifecore Biomedical is more profitable, with an operating margin of -3.5% against -401.8%.
Where the money goes: VRDN and LFCR
Viridian Therapeutics (VRDN) · Q3 2026
Viridian Therapeutics, Q3 2026: revenue $25.8M (-64% year over year), operating margin -401.8%, net loss $101M, operating cash flow −$92.8M. The chart follows the revenue to costs, profit and cash.
Lifecore Biomedical (LFCR) · Q1 FY27
Lifecore Biomedical, Q1 FY27: revenue $25.3M (-19% year over year), operating margin -3.5%, net loss $40.1M, operating cash flow $6.9M. The chart follows the revenue to costs, profit and cash.
| Viridian Therapeutics (VRDN) | Lifecore Biomedical (LFCR) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q1 FY27 |
| Revenue | $25.8M | $25.3M |
| Revenue growth, Y/Y | -64% | -19% |
| Operating margin | -401.8% | -3.5% |
| Net earnings | −$101M | −$40.1M |
| Net margin | -393.0% | -158.3% |
| Operating cash flow | −$92.8M | $6.9M |
| Free cash flow | — | $6.0M |
Where the revenue comes from
Viridian Therapeutics
- Product revenue, net: $24.7M (96%)
- Collaboration revenue: $956K (4%)
- License revenue: $125K (0%)
Lifecore Biomedical
- CDMO: $17.8M (70%)
- HA manufacturing: $7.5M (30%)
Questions
Which is bigger, Viridian Therapeutics or Lifecore Biomedical?
Viridian Therapeutics is the larger company: $25.8M of revenue in its latest quarter (Q3 2026) against $25.3M for Lifecore Biomedical (Q1 FY27).
Is Viridian Therapeutics or Lifecore Biomedical growing faster?
Lifecore Biomedical is growing faster (-19% against -64% a year earlier).
Which is more profitable, Viridian Therapeutics or Lifecore Biomedical?
Lifecore Biomedical is more profitable, with an operating margin of -3.5% against -401.8%.
More: Viridian Therapeutics earnings · how Viridian Therapeutics makes money · Lifecore Biomedical earnings · how Lifecore Biomedical makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 4, 2026; 10-Q filed Nov 4, 2026). Fiscal quarters can end on different dates. Not investment advice.